R. V. Likhar and S. Joshi, “Recent development of heterocyclic scaffolds as EGFR kinase inhibitors in cancer”, Curr. Issues Pharm. Med. Sci., vol. 38, no. 2, pp. 112–121, May 2025, doi: 10.12923/cipms-2025-0018.